Reproductive performance of female rats treated with cyclophosphamide and/or LHRH agonist

Reproductive Toxicology

Volumn 7, Issue 3, 1993, Pages 229-235

  Ataya, Khalid ^a   Ramahi Ataya, Alfida ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

chemotherapy; cyclophosphamide; fertility; implantation sites; LHRH agonist; postponing menopause

Indexed keywords

CYCLOPHOSPHAMIDE; DRUG DERIVATIVE; GONADORELIN; LEUPRORELIN;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; DRUG INTERACTION; ESTRUS; FEMALE; FERTILITY; MALE; PHYSIOLOGY; RAT; RAT STRAIN; REPRODUCTION; VAGINA SMEAR;

ANIMAL; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; DRUG INTERACTIONS; ESTRUS; FEMALE; FERTILITY; GONADORELIN; LEUPROLIDE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VAGINAL SMEARS;

EID: 0027600168     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/0890-6238(93)90229-Z     Document Type: Article

References (32)

1. Cyclophosphamide and cisdichlorodiamine platinum 2. Nonempiric scheduling to spare dose-limiting tissues in the rat
2. A luteinizing hormone-releasing hormone agonist for the prevention of chemotherapy-induced ovarian follicular loss in rats
3. Cytotoxic ovarian failure in women with Hodgkin's disease 1. Hormone function
4. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy of Hodgkin's disease
5. Effects of long-term estrogen replacement therapy
6. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease
7. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease
8. The protection of ovarian follicles from ionizing radiation with the agonist LHRH ethylamide
9. Antineoplastic agents
10. Cyclophosphamide and reproductive function
11. Cyclophosphamide induced ovarian failure
12. The growth of follicles in the rat ovary under the influence of busulphan and endoxan
13. Changes in mouse ovaries after prolonged treatment with cyclophosphamide
14. Effect of cyclophosphamide on the immature rat ovary
15. 3H-thymidine uptake by luteinizing hormone-releasing hormone agonists: a possible mechanism for preventing damage by cytotoxic agents
16. Effect of cyclophosphamide on mouse oocyte in vitro fertilization and cleavage: recovery
17. GnRH agonist inhibits physiologic ovarian follicular loss in rats
18. Early treatment of young female rats with progesterone delays the aging-associated reproductive decline: a counteraction by estradiol
19. Relation of parity and estrus cyclicity to the biology of pregnancy in aging female rats
20. Principles of radiation therapy
21. Cell cycle effects of alkylating agents
22. 3HT) incorporation into ovarian DNA in rats: a potential mechanism for preventing damage by cytotoxic agents
23. 3HT) incorporation into ovarian DNA in rhesus monkeys (RhM): a potential mechanism for preventing damage by cytotoxic agents
24. Hormonal regulation of ovarian cellular proliferation
25. 3H] thymidine infusion: a method for the study of follicular dynamics
26. The effect of “activated” cyclophosphamide on rat granulosa cells in vitro
27. The effect of “activated” cyclophosphamide on human and rat ovarian granulosa cells in vitro
28. Effect of “activated” cyclophosphamide on mouse oocyte in vitro fertilization and cleavage
29. Pregnancy outcome following cancer chemotherapy
30. Chemotherapy-induced ovarian failure: mechanisms and prevention
31. Effects of LHRH agonists on body weight in rats